Differential Ly-6C expression identifies the recruited macrophage phenotype, which orchestrates the regression of murine liver fibrosis
Open accessThe DOI matches its Crossref record; 60 of the 60 references it cites were found in a registry or an index.
Abstract
Although macrophages are widely recognized to have a profibrotic role in inflammation, we have used a highly tractable CCl 4 -induced model of reversible hepatic fibrosis to identify and characterize the macrophage phenotype responsible for tissue remodeling: the hitherto elusive restorative macrophage. This CD11B hi F4/80 int Ly-6C lo macrophage subset was most abundant in livers during maximal fibrosis resolution and represented the principle matrix metalloproteinase (MMP) -expressing subset. Depletion of this population in CD11B promoter–diphtheria toxin receptor (CD11B-DTR) transgenic mice caused a failure of scar remodeling. Adoptive transfer and in situ labeling experiments showed that these restorative macrophages derive from recruited Ly-6C hi monocytes, a common origin with profibrotic Ly-6C hi macrophages, indicative of a phenotypic switch in vivo conferring proresolution properties. Microarray profiling of the Ly-6C lo subset, compared with Ly-6C hi macrophages, showed a phenotype outside the M1/M2 classification, with increased expression of MMPs, growth factors, and phagocytosis-related genes, including Mmp9, Mmp12, insulin-like growth factor 1 (Igf1), and Glycoprotein (transmembrane) nmb (Gpnmb). Confocal microscopy confirmed the postphagocytic nature of restorative macrophages. Furthermore, the restorative macrophage phenotype was recapitulated in vitro by the phagocytosis of cellular debris with associated activation of the ERK signaling cascade. Critically, induced phagocytic behavior in vivo, through administration of liposomes, increased restorative macrophage number and accelerated fibrosis resolution, offering a therapeutic strategy to this orphan pathological process.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Restorative (or pro-resolving) macrophages contribute to extracellular matrix degradation, myofibroblast inactivation, and tissue remodeling.”
From Strategies to promote liver fibrosis amelioration with involvement of restorative macrophages (2026) · cites this paper as [1]
In the citing paper
“The Ly6clow macrophages display a restorative phenotype that can promote fibrosis resolution (6).”
From Stiffness sensing via Piezo1 enhances macrophage efferocytosis and promotes the resolution of liver fibrosis (2024) · cites this paper as [6]
In the citing paper
“Most of the existing knowledge regarding liver fibrosis resolution is derived from mouse models of chemical (CCl4 or acetaminophen)-induced fibrosis and regression (17–21).”
From Lipid-associated macrophages' promotion of fibrosis resolution during MASH regression requires TREM2 (2024) · cites this paper as [20]
In the citing paper
“During regression of CCl4-induced liver fibrosis, a new Ly6clo restorative macrophage population emerges that play a pivotal role in orchestrating fibrosis resolution, in part through the expression of matrix-degrading metalloproteinases (MMPs) (17, 20).”
From Lipid-associated macrophages' promotion of fibrosis resolution during MASH regression requires TREM2 (2024) · cites this paper as [20]
In the citing paper
“Interestingly, pro-resolution infiltrating CD11b(hi)F4/80(int)Ly-6C(lo) MΦ subset demonstrate a post-phagocytic phenotype, which was further enhanced by the administration of non-loaded liposomes in vivo25.”
From Hepatocyte mitochondria-derived danger signals directly activate hepatic stellate cells and drive progression of liver fibrosis (2020) · cites this paper as [25]
11 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources
Huang, D. W., Sherman, B. T., & Lempicki, R. A. (2009) · Nature Protocols · doi:10.1038/nprot.2008.211 · Cited by 35,890
DAVID: Database for Annotation, Visualization, and Integrated Discovery
Dennis, G., Sherman, B. T., Hosack, D. A., Yang, J., Gao, W., Lane, H. C., & Lempicki, R. A. (2003) · Genome Biology · doi:10.1186/gb-2003-4-5-p3 · Cited by 9,327 · cited 2×
“We performed pathway enrichment analysis on the differentially regulated genes from the two macrophage populations using the DAVID bioinformatics tool (36, 37).”
Exploring the full spectrum of macrophage activation
Mosser, D. M., & Edwards, J. P. (2008) · Nature Reviews Immunology · doi:10.1038/nri2448 · Cited by 9,144 · cited 4×
“This finding is in keeping with the known ability of monocytes and macrophages to change phenotype in situ depending on local environmental cues (13).”
InfluentialThe chemokine system in diverse forms of macrophage activation and polarization
MANTOVANI, A., SICA, A., SOZZANI, S., ALLAVENA, P., VECCHI, A., & LOCATI, M. (2004) · Trends in Immunology · doi:10.1016/j.it.2004.09.015 · Cited by 6,534 · cited 7×
“Macrophages are capable of distinct activation states and functions, which in vitro, can be broadly classified asM1 (classical) or M2 (alternative) (13, 14).”
InfluentialMonocyte and macrophage heterogeneity
Gordon, S., & Taylor, P. R. (2005) · Nature Reviews Immunology · doi:10.1038/nri1733 · Cited by 5,190 · cited 3×
“Differential Ly-6C expression has been widely used to identify functionally distinct populations of circulating murine monocytes (15, 16) and macrophage populations in pathology (17–21).”
Cellular and molecular mechanisms of fibrosis
Wynn, T. (2008) · The Journal of Pathology · doi:10.1002/path.2277 · Cited by 4,495
Nahrendorf, M., Swirski, F. K., Aikawa, E., Stangenberg, L., Wurdinger, T., Figueiredo, J.-L., Libby, P., Weissleder, R., & Pittet, M. J. (2007) · The Journal of Experimental Medicine · doi:10.1084/jem.20070885 · Cited by 2,300
Transcriptional regulation of macrophage polarization: enabling diversity with identity
Lawrence, T., & Natoli, G. (2011) · Nature Reviews Immunology · doi:10.1038/nri3088 · Cited by 2,284 · cited 5×
“Although Ly-6Clo restorative macrophages show increased expression of some M2 genes, such as Macrophage Mannose receptor 1 (Mrc1), Arginase-1 (Arg1), and Retnla (Fizz-1), they also down-regulate other characteristic M2 genes, including Chi3l3 (YM-1), Il-1 receptor antagonist (Il1rn), Kdm6b (Jmjd3), Ccl24, Il-10, and T…”
InfluentialMartinez, F. O., Gordon, S., Locati, M., & Mantovani, A. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.10.7303 · Cited by 2,125 · cited 1×
“Simultaneously, these Ly-6C macrophages up-regulate traditional M1 genes, such as Ciita (MHC class II transactivator), CD16, CD32, and Serpine1 (plasminogen activator inhibitor type 1) (14, 40, 41).”
Arnold, L., Henry, A., Poron, F., Baba-Amer, Y., van Rooijen, N., Plonquet, A., Gherardi, R. K., & Chazaud, B. (2007) · The Journal of Experimental Medicine · doi:10.1084/jem.20070075 · Cited by 2,002 · cited 1×
“Phagocytosis can elicit significant effects on macrophage phenotype and function (19, 42).”
Rooijen, N. V., & Sanders, A. (1994) · Journal of Immunological Methods · doi:10.1016/0022-1759(94)90012-4 · Cited by 1,779 · cited 1×
“vol) diluted 1:25 in PBS for injection; Polysciences Inc] or vehicle control; and (iii) 250 μL liposomes (60) (provided by N.”
Selective depletion of macrophages reveals distinct, opposing roles during liver injury and repair
Duffield, J. S., Forbes, S. J., Constandinou, C. M., Clay, S., Partolina, M., Vuthoori, S., Wu, S., Lang, R., & Iredale, J. P. (2005) · Journal of Clinical Investigation · doi:10.1172/jci200522675 · Cited by 1,649 · cited 5×
“However, it has recently been shown that they also play a pivotal role in fibrosis regression (6, 11), in part through expression of matrix-degrading metalloproteinase enzymes (MMPs) (12).”
InfluentialSelf-citationA blast from the past: clearance of apoptotic cells regulates immune responses
Savill, J., Dransfield, I., Gregory, C., & Haslett, C. (2002) · Nature Reviews Immunology · doi:10.1038/nri957 · Cited by 1,574 · cited 2×
“Phagocytosis can elicit significant effects on macrophage phenotype and function (19, 42).”
Macrophages: master regulators of inflammation and fibrosis
Wynn, T., & Barron, L. (2010) · Seminars in Liver Disease · doi:10.1055/s-0030-1255354 · Cited by 1,392 · cited 1×
“Although evidence for a central role for macrophages in inflammation and tissue fibrogenesis has been described across organ systems (8), data have recently emerged to suggest a functional heterogeneity of subtypes in vivo and a role in fibrosis resolution (3, 6, 11, 12).”
Jenkins, S. J., Ruckerl, D., Cook, P. C., Jones, L. H., Finkelman, F. D., van Rooijen, N., MacDonald, A. S., & Allen, J. E. (2011) · Science · doi:10.1126/science.1204351 · Cited by 1,366 · cited 3×
“(31), where resident F4/80 pleural macrophages proliferated during chronic parasitic infection.”
InfluentialTacke, F., Alvarez, D., Kaplan, T. J., Jakubzick, C., Spanbroek, R., Llodra, J., Garin, A., Liu, J., Mack, M., van Rooijen, N., et al. (2007) · Journal of Clinical Investigation · doi:10.1172/jci28549 · Cited by 1,323 · cited 1×
“To determine the relative contribution of Ly-6C monocytes to the hepatic macrophage subsets, we used a well-validated in vivo labeling technique (29, 30).”
Integrating mechanisms of pulmonary fibrosis
Wynn, T. A. (2011) · Journal of Experimental Medicine · doi:10.1084/jem.20110551 · Cited by 1,274 · cited 1×
“Key questions arising from studies regarding the divergent role of macrophages in fibrogenesis and recovery were whether these distinct functions were mediated by resident or recruited cells and whether those cells underwent a phenotypic switch in situ (55, 56).”
Movahedi, K., Laoui, D., Gysemans, C., Baeten, M., Stangé, G., Van den Bossche, J., Mack, M., Pipeleers, D., In't Veld, P., De Baetselier, P., et al. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-4672 · Cited by 1,239
Subpopulations of Mouse Blood Monocytes Differ in Maturation Stage and Inflammatory Response
Sunderkötter, C., Nikolic, T., Dillon, M. J., van Rooijen, N., Stehling, M., Drevets, D. A., & Leenen, P. J. M. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.7.4410 · Cited by 1,124 · cited 1×
“The degree of depletion was more profound for the Ly-6C monocytes in keeping with them being a more mature cell type forming from differentiation of Ly-6C monocytes (15) and thus, taking longer to replenish after depletion (24).”
Karlmark, K. R., Weiskirchen, R., Zimmermann, H. W., Gassler, N., Ginhoux, F., Weber, C., Merad, M., Luedde, T., Trautwein, C., & Tacke, F. (2009) · Hepatology · doi:10.1002/hep.22950 · Cited by 782 · cited 3×
“The profibrotic Ly-6C macrophage subset has been shown to derive from a Chemokine (C-C motif) receptor 2 (CCR2)-dependent recruitment of circulating Ly-6C monocytes (21).”
InfluentialComparison of gene expression profiles between human and mouse monocyte subsets
Ingersoll, M. A., Spanbroek, R., Lottaz, C., Gautier, E. L., Frankenberger, M., Hoffmann, R., Lang, R., Haniffa, M., Collin, M., Tacke, F., et al. (2010) · Blood · doi:10.1182/blood-2009-07-235028 · Cited by 729
Chi, H., Barry, S. P., Roth, R. J., Wu, J. J., Jones, E. A., Bennett, A. M., & Flavell, R. A. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0510965103 · Cited by 569 · cited 1×
“Administration of a p38 MAPK inhibitor (SB203580; 10 μM) at a published dose (51) had no effect on macrophage expression of Mmp9, Mmp12, or Igf1 in response to phagocytosis (Fig.”
Macrophages as APC and the Dendritic Cell Myth
Hume, D. A. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.9.5829 · Cited by 501 · cited 1×
“CD11c+ dendritic cells (DCs) have been associated with resolution of liver injury (25, 26) and share a number of cell surface markers with macrophages (27).”
Henson, P. M., Bratton, D. L., & Fadok, V. A. (2001) · Current Biology · doi:10.1016/s0960-9822(01)00474-2 · Cited by 486 · cited 1×
“These findings are consistent with the known ability of monocytes to bind apoptotic debris, but a delayed capacity to ingest until differentiation into a more mature macrophage subtype has occurred (43, 44).”
Fallowfield, J. A., Mizuno, M., Kendall, T. J., Constandinou, C. M., Benyon, R. C., Duffield, J. S., & Iredale, J. P. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.178.8.5288 · Cited by 479 · cited 5×
“However, it has recently been shown that they also play a pivotal role in fibrosis regression (6, 11), in part through expression of matrix-degrading metalloproteinase enzymes (MMPs) (12).”
InfluentialSelf-citationLy6Chi monocytes direct alternatively activated profibrotic macrophage regulation of lung fibrosis
Gibbons, M. A., MacKinnon, A. C., Ramachandran, P., Dhaliwal, K., Duffin, R., Phythian-Adams, A. T., van Rooijen, N., Haslett, C., Howie, S. E., Simpson, A. J., et al. (2011) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201010-1719oc · Cited by 466 · cited 3×
“Long thought of as inexorably progressive, recent evidence, particularly in the liver (3) but also the kidney (4), lung (5, 6), and heart (7), indicates that some reversibility exists, even in advanced disease.”
Self-citationHolt, M. P., Cheng, L., & Ju, C. (2008) · Journal of Leukocyte Biology · doi:10.1189/jlb.0308173 · Cited by 399 · cited 2×
“The CD11B F4/80 subset represents a recruited monocyte-derived macrophage population (22).”
Modulation of cardiac macrophages by phosphatidylserine-presenting liposomes improves infarct repair
Harel-Adar, T., Mordechai, T. B., Amsalem, Y., Feinberg, M. S., Leor, J., & Cohen, S. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1015623108 · Cited by 362
Marim, F. M., Silveira, T. N., Lima, D. S., & Zamboni, D. S. (2010) · PLoS ONE · doi:10.1371/journal.pone.0015263 · Cited by 351 · cited 1×
“Primary bone marrow-derived macrophages (BMDMs), widely used to study macrophage biology in vitro (45), were cultured in the presence and absence of cell debris generated from strainmatched primary murine hepatocytes.”
Lin, S. L., Castaño, A. P., Nowlin, B. T., Lupher, M. L., & Duffield, J. S. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0901473 · Cited by 326 · cited 2×
“In concordance with previous data (17), administration of DT was effective in depleting both populations of circulating monocytes (Ly-6C and Ly-6C) (Fig.”
Newman, S. L., Henson, J. E., & Henson, P. M. (1982) · The Journal of experimental medicine · doi:10.1084/jem.156.2.430 · Cited by 318 · cited 1×
“These findings are consistent with the known ability of monocytes to bind apoptotic debris, but a delayed capacity to ingest until differentiation into a more mature macrophage subtype has occurred (43, 44).”
Tacke, F., Ginhoux, F., Jakubzick, C., van Rooijen, N., Merad, M., & Randolph, G. J. (2006) · The Journal of Experimental Medicine · doi:10.1084/jem.20052119 · Cited by 281 · cited 1×
“To determine the relative contribution of Ly-6C monocytes to the hepatic macrophage subsets, we used a well-validated in vivo labeling technique (29, 30).”
CD11c depletion severely disrupts Th2 induction and development in vivo
Phythian-Adams, A. T., Cook, P. C., Lundie, R. J., Jones, L. H., Smith, K. A., Barr, T. A., Hochweller, K., Anderton, S. M., Hämmerling, G. J., Maizels, R. M., et al. (2010) · Journal of Experimental Medicine · doi:10.1084/jem.20100734 · Cited by 270 · cited 5×
“Furthermore, administration of DT to chronically injured CD11c-DOG mice at a dose known to deplete hepatic DCs (28) had no effect on the identified hepatic macrophage subsets (Fig.”
InfluentialKarlmark, K. R., Zimmermann, H. W., Roderburg, C., Gassler, N., Wasmuth, H. E., Luedde, T., Trautwein, C., & Tacke, F. (2010) · Hepatology · doi:10.1002/hep.23894 · Cited by 249 · cited 1×
“Chemokine (C-X3-C) receptor 1 (CX3CR1)] (32) or antifibrotic effects (e.”
Chung, E. Y., Liu, J., Homma, Y., Zhang, Y., Brendolan, A., Saggese, M., Han, J., Silverstein, R., Selleri, L., & Ma, X. (2007) · Immunity · doi:10.1016/j.immuni.2007.11.014 · Cited by 248 · cited 1×
“MAPK signaling, specifically the ERK and p38 cascades, is activated in macrophages after phagocytosis, and it has been reported to regulate a number of macrophage responses (47, 48).”
Emerging Concepts in the Pathogenesis of Lung Fibrosis
Hardie, W. D., Glasser, S. W., & Hagood, J. S. (2009) · The American Journal of Pathology · doi:10.2353/ajpath.2009.081170 · Cited by 240 · cited 1×
“Eddy AA (2005) Can renal fibrosis be reversed? Pediatr Nephrol 20(10):1369–1375.”
Dual Role of CCR2 in the Constitution and the Resolution of Liver Fibrosis in Mice
Mitchell, C., Couton, D., Couty, J.-P., Anson, M., Crain, A.-M., Bizet, V., Rénia, L., Pol, S., Mallet, V., & Gilgenkrantz, H. (2009) · The American Journal of Pathology · doi:10.2353/ajpath.2009.080632 · Cited by 189 · cited 1×
“(58): that decreased CCR2-dependent recruitment of Ly-6C monocytes retards fibrosis resolution (58).”
Conventional DCs reduce liver ischemia/reperfusion injury in mice via IL-10 secretion
Bamboat, Z. M., Ocuin, L. M., Balachandran, V. P., Obaid, H., Plitas, G., & DeMatteo, R. P. (2010) · Journal of Clinical Investigation · doi:10.1172/jci40008 · Cited by 184 · cited 1×
“CD11c+ dendritic cells (DCs) have been associated with resolution of liver injury (25, 26) and share a number of cell surface markers with macrophages (27).”
Macrophages and Renal Fibrosis
Vernon, M. A., Mylonas, K. J., & Hughes, J. (2010) · Seminars in Nephrology · doi:10.1016/j.semnephrol.2010.03.004 · Cited by 160
Self-citationHeinrichs, D., Knauel, M., Offermanns, C., Berres, M.-L., Nellen, A., Leng, L., Schmitz, P., Bucala, R., Trautwein, C., Weber, C., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1107023108 · Cited by 159 · cited 4×
“Heinrichs D, et al. (2011) Macrophage migration inhibitory factor (MIF) exerts antifibrotic effects in experimental liver fibrosis via CD74.”
InfluentialDendritic Cell Regulation of Carbon Tetrachloride–Induced Murine Liver Fibrosis Regression
Jiao, J., Sastre, D., Fiel, M. I., Lee, U. E., Ghiassi–Nejad, Z., Ginhoux, F., Vivier, E., Friedman, S. L., Merad, M., & Aloman, C. (2012) · Hepatology · doi:10.1002/hep.24621 · Cited by 154
Valledor, A. F., Comalada, M., Xaus, J., & Celada, A. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.10.7403 · Cited by 135 · cited 1×
“To show a functional role for ERK signaling in the observed macrophage phenotype, we administered the specific ERK kinase [mitogen-activated protein kinase kinase 1 and 2 (MEK1/2)] inhibitor PD98059 (50 μM) or vehicle control to BMDMs at published doses (49, 50) for 1 h before and during feeding with hepatocyte debris…”
Functional role of chemokines in liver disease models
Sahin, H., Trautwein, C., & Wasmuth, H. E. (2010) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2010.168 · Cited by 107 · cited 2×
“These findings have implications for development of antifibrotic therapies, where targeting inflammatory monocyte recruitment might adversely impact on the population of restorative Ly-6C macrophages (39, 57).”
Sobrevals, L., Rodriguez, C., Romero-Trevejo, J. L., Gondi, G., Monreal, I., Pañeda, A., Juanarena, N., Arcelus, S., Razquin, N., Guembe, L., et al. (2010) · Hepatology · doi:10.1002/hep.23412 · Cited by 99 · cited 6×
“We also identified additional proresolution mechanisms, such as a strong increase in expression of insulin-like growth factor 1 (Igf1), which has been implicated as being antifibrotic (35) (Fig.”
InfluentialReversibility of liver fibrosis
Ramachandran, P., & Iredale, J. P. (2009) · Annals of Hepatology · doi:10.1016/s1665-2681(19)31740-5 · Cited by 98
Self-citationMac the knife? Macrophages– the double-edged sword of hepatic fibrosis
Friedman, S. L. (2005) · Journal of Clinical Investigation · doi:10.1172/jci200523928 · Cited by 95 · cited 1×
“Key questions arising from studies regarding the divergent role of macrophages in fibrogenesis and recovery were whether these distinct functions were mediated by resident or recruited cells and whether those cells underwent a phenotypic switch in situ (55, 56).”
Macrophages Expressing Heme Oxygenase-1 Improve Renal Function in Ischemia/Reperfusion Injury
Ferenbach, D. A., Ramdas, V., Spencer, N., Marson, L., Anegón, I., Hughes, J., & Kluth, D. (2010) · Molecular Therapy · doi:10.1038/mt.2010.100 · Cited by 88 · cited 1×
“To confirm the active secretion of MMPs and determine if this effect was a general effect of phagocytosis on macrophages independent of the type of debris, we used the well-described model of phagocytosis of apoptotic thymocytes (46).”
Parenchymal Extinction: Coagulation and Hepatic Fibrogenesis
Anstee, Q. M., Wright, M., Goldin, R. D., & Thursz, M. R. (2009) · Clinics in Liver Disease · doi:10.1016/j.cld.2008.09.013 · Cited by 85 · cited 1×
“S6A), which are important for fibrogenesis (38, 39).”
Raza, S. L., Nehring, L. C., Shapiro, S. D., & Cornelius, L. A. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m005788200 · Cited by 85 · cited 1×
“To show a functional role for ERK signaling in the observed macrophage phenotype, we administered the specific ERK kinase [mitogen-activated protein kinase kinase 1 and 2 (MEK1/2)] inhibitor PD98059 (50 μM) or vehicle control to BMDMs at published doses (49, 50) for 1 h before and during feeding with hepatocyte debris…”
Breitkopf, K., Sawitza, I., Westhoff, J. H., Wickert, L., Dooley, S., & Gressner, A. M. (2005) · Gut · doi:10.1136/gut.2004.042911 · Cited by 77
Cortez‐Retamozo, V., Świrski, F. K., Waterman, P. R., Yuan, H., de Figueiredo, J. L., Newton, A., Upadhyay, R., Vinegoni, C., Köhler, R. H., Blois, J. T., et al. (2008) · Journal of Clinical Investigation · doi:10.1172/jci36335 · Cited by 73 · cited 1×
“To identify the principle hepaticMMP-expressingmacrophage subset, we used a pan-MMP substrate (MMPsense), which becomes fluorescent after cleavage by activeMMPs in vivo (23), enabling us to identify a population of MMPsense-positive hepatic macrophages by flow cytometry (Fig.”
Targeting the Recruitment of Monocytes and Macrophages in Renal Disease
Vielhauer, V., Kulkarni, O. P., Reichel, C. A., & Anders, H. (2010) · Seminars in Nephrology · doi:10.1016/j.semnephrol.2010.03.006 · Cited by 70 · cited 1×
“These findings have implications for development of antifibrotic therapies, where targeting inflammatory monocyte recruitment might adversely impact on the population of restorative Ly-6C macrophages (39, 57).”
Mei, H., Wu, Z., & Nakanishi, H. (2011) · Laboratory Investigation · doi:10.1038/labinvest.2011.54 · Cited by 68 · cited 1×
“Furthermore, recent studies have shown that liposome administration can alter macrophage phenotype in vivo in part by induction of ERK signaling after ingestion (53, 54).”
O’Connor, R. A., Leech, M. D., Suffner, J., Hämmerling, G. J., & Anderton, S. M. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.1001551 · Cited by 59
Can renal fibrosis be reversed?
Eddy, A. A. (2005) · Pediatric Nephrology · doi:10.1007/s00467-005-1995-5 · Cited by 58
High-Dose Enalapril Treatment Reverses Myocardial Fibrosis in Experimental Uremic Cardiomyopathy
Tyralla, K., Adamczak, M., Benz, K., Câmpean, V., Groß, M.-L., Hilgers, K. F., Ritz, E., & Amann, K. (2011) · PLoS ONE · doi:10.1371/journal.pone.0015287 · Cited by 34 · cited 1×
“Long thought of as inexorably progressive, recent evidence, particularly in the liver (3) but also the kidney (4), lung (5, 6), and heart (7), indicates that some reversibility exists, even in advanced disease.”
Kurosaka, K., Takahashi, M., & Kobayashi, Y. (2003) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(03)01105-7 · Cited by 29
Fluorescent liposomes as quantitative markers of phagocytosis by alveolar macrophages
Perry, D. G., & Martin, W. J. (1995) · Journal of Immunological Methods · doi:10.1016/0022-1759(95)00011-x · Cited by 27 · cited 1×
“Liposome uptake by macrophages represents a genuine phagocytosis event (52), and it has been widely used to target macrophages in vivo.”
Radiation-induced pulmonary fibrosis resolves spontaneously if dense scars are not formed
Pickrell, J., Diel, J. H., Slauson, D. O., Halliwell, W. H., & Mauderly, J. L. (1983) · Experimental and Molecular Pathology · doi:10.1016/0014-4800(83)90095-3 · Cited by 19 · cited 2×
“Long thought of as inexorably progressive, recent evidence, particularly in the liver (3) but also the kidney (4), lung (5, 6), and heart (7), indicates that some reversibility exists, even in advanced disease.”
Hayden, T. (2011) · Nature Medicine · doi:10.1038/nm0111-18 · Cited by 10 · cited 1×
“A the generic and common pathological endpoint to chronic injury, fibrosis has been estimated to contribute to 45% of all deaths in industrialized nations (1, 2).”
Research works printed but not linked: 5
- T Hayden, Scarred by disease. Nat Med 17, 18–20 (2011). · DOI
- P Ramachandran, JP Iredale, Reversibility of liver fibrosis. Ann Hepatol 8, 283–291 (2009). · DOI · Paper page
- JS Duffield, et al., Selective depletion of macrophages reveals distinct, opposing roles during liver injury and repair. J Clin Invest 115, 56–65 (2005). · DOI · Paper page
- DM Mosser, JP Edwards, Exploring the full spectrum of macrophage activation. Nat Rev Immunol 8, 958–969 (2008). · DOI · Paper page
- KR Karlmark, et al., Hepatic recruitment of the inflammatory Gr1+ monocyte subset upon liver injury promotes hepatic fibrosis. Hepatology 50, 261–274 (2009). · DOI · Paper page
Cited by
Macrophages in Tissue Repair, Regeneration, and Fibrosis
Wynn, T. A., & Vannella, K. M. (2016) · Immunity · doi:10.1016/j.immuni.2016.02.015 · Cited by 4,481
Mechanisms of hepatic stellate cell activation
Tsuchida, T., & Friedman, S. L. (2017) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2017.38 · Cited by 2,909
Molecular and cellular mechanisms of liver fibrosis and its regression
Kisseleva, T., & Brenner, D. (2021) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-020-00372-7 · Cited by 2,024
Mechanisms and disease consequences of nonalcoholic fatty liver disease
Loomba, R., Friedman, S. L., & Shulman, G. I. (2021) · Cell · doi:10.1016/j.cell.2021.04.015 · Cited by 2,002
Resolving the fibrotic niche of human liver cirrhosis at single-cell level
Ramachandran, P., Dobie, R., Wilson-Kanamori, J. R., Dora, E. F., Henderson, B. E. P., Luu, N. T., Portman, J. R., Matchett, K. P., Brice, M., Marwick, J. A., et al. (2019) · Nature · doi:10.1038/s41586-019-1631-3 · Cited by 1,784
Self-citation
Metadata
- Authors
- Ramachandran, P., Pellicoro, A., Vernon, M. A., Boulter, L., Aucott, R. L., Ali, A., Hartland, S. N., Snowdon, V. K., Cappon, A., Gordon-Walker, T. T., Williams, M. J., Dunbar, D. R., Manning, J. R., van Rooijen, N., Fallowfield, J. A., Forbes, S. J., & Iredale, J. P.
- Affiliations
- Centre for Inflammation Research (GB)
- University of Padua (IT)
- University of Edinburgh/Medical Research Council Centre for Inflammation Research and
- The Queen's Medical Research Institute (GB)
- Department of Molecular Cell Biology, Vrije Universiteit, 1081 BT, Amsterdam, The Netherlands
- Corresponding author
- Iredale, John P.
- ORCID
- Venue
- Proceedings of the National Academy of Sciences
- Publisher
- National Academy of Sciences
- Published
- 2012-10-24
- Volume
- 109
- Issue
- 46
- Pages
- E3186-95
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- PMC
- PMC3503234
- OpenAlex
- W2163386417
- Semantic Scholar
- 8fe6c7938818cb1f90873273b4763e8abd285c65
- Cited by
- 1,001
- References
- 60
- Citations by year
- 2026: 60 · 2025: 82 · 2024: 75 · 2023: 72 · 2022: 96 · 2021: 97 · 2020: 72 · 2019: 78 · 2018: 73 · 2017: 74 · 2016: 68 · 2015: 74 · 2014: 49 · 2013: 28 · 2012: 1
- FWCI
- 30.84
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Proceedings of the National Academy of Sciences (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Edinburgh Research Explorer (University of Edinburgh) (submittedVersion, other-oa)
- Funders
- Wellcome Trust
- British Heart Foundation
- Academy of Medical Sciences (AMS-CSF3-Fallowfield)
- Royal College of Surgeons of Edinburgh
- Medical Research Council (MR/K001744/1)
- Biotechnology and Biological Sciences Research Council (BBS/E/D/20310000)
- Topics
- Health Sciences › Medicine › Hepatology › Liver physiology and pathology
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac Fibrosis and Remodeling
- Life Sciences › Immunology and Microbiology › Immunology › Immune cells in cancer
- Keywords
- liver fibrosis, macrophage phenotype, Ly6C, fibrosis resolution, matrix metalloproteinases, MMP-9, MMP-12, GPNMB, insulin-like growth factor I, phagocytosis, monocyte recruitment, ERK signaling, scar remodeling, CCl4-induced fibrosis
- MeSH terms
- Animals, Antigens, Ly, Carbon Tetrachloride, Carbon Tetrachloride Poisoning, Gene Expression Regulation, Insulin-Like Growth Factor I, Liver Cirrhosis, Macrophages, Mice, Transgenic, Monocytes, Matrix Metalloproteinase 9, MAP Kinase Signaling System, CD11b Antigen, Mice, Matrix Metalloproteinase 12
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.